BDBM50139080 (S)-3-{4-[3-(2,6-Dichloro-phenyl)-ureido]-phenyl}-2-{[2-(toluene-4-sulfonyl)-2-aza-bicyclo[2.2.2]octane-3-carbonyl]-amino}-propionic acid::CHEMBL347669

SMILES Cc1ccc(S(=O)(=O)N2C3CCC(CC3)C2C(=O)N[C@@H](Cc2ccc(NC(=O)Nc3c(Cl)cccc3Cl)cc2)C(=O)O)cc1

InChI Key InChIKey=CGMCDTAIHSLRBR-UHFFFAOYSA-N

Data  1 IC50

  Tab Delimited (TSV)   2D SDfile   Computed 3D by Vconf -m prep SDfile
Find this compound or compounds like it in BindingDB:
   Substructure
Similarity at least:  must be >=0.5
Exact match

Activity Spreadsheet -- Enzyme Inhibition Constant Data from BindingDB

Found 1 hit for monomerid = 50139080   

TargetIntegrin alpha-4/beta-1(Human)
Johnson & Johnson Pharmaceutical Research & Development

Curated by ChEMBL
LigandChemical structure of BindingDB Monomer ID 50139080BDBM50139080((S)-3-{4-[3-(2,6-Dichloro-phenyl)-ureido]-phenyl}-...)
Affinity DataIC50: 1.60E+3nMAssay Description:In vitro inhibition of binding of integrin alpha4-beta1 to immobilized VCAM-1 expressed on endothelial cell surface.More data for this Ligand-Target Pair
In Depth
Date in BDB:
11/10/2009
Entry Details Article
PubMed